drugset / Trial / NCT06639087
A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment
RandomizedParallel-groupTriple-blindTreatment
Summary
A study to investigate the effects and safety of AZD5462 on top of dapagliflozin in participants with heart failure and moderate renal impairment.
Timeline
- Start
- 2024-09-27
- Primary completion
- 2025-05-29
- Completion
- 2025-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD5462 | Unknown | — | — |
| Comparator | Dapagliflozin | Small molecule | — | — |